Evidence map›Paper›PMID 34458936›Full record

ArticleApplied microbiology and biotechnology2021

Endo-xylanases from Cohnella sp. AR92 aimed at xylan and arabinoxylan conversion into value-added products.

Johan S Hero, José H Pisa, Cintia M Romero, Eva Nordberg Karlsson, Javier A Linares-Pastén, M Alejandra Martinez

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Comparative genomic analysis ofFrontiers in microbiology · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Johan S HeroPlanta Piloto de Procesos Industriales Microbiológicos PROIMI-CONICET, Av. Belgrano Y Pasaje Caseros, T4001 MVB, 4000, San Miguel de Tucumán, Argentina.
José H PisaPlanta Piloto de Procesos Industriales Microbiológicos PROIMI-CONICET, Av. Belgrano Y Pasaje Caseros, T4001 MVB, 4000, San Miguel de Tucumán, Argentina.
Cintia M RomeroPlanta Piloto de Procesos Industriales Microbiológicos PROIMI-CONICET, Av. Belgrano Y Pasaje Caseros, T4001 MVB, 4000, San Miguel de Tucumán, Argentina.
Eva Nordberg KarlssonBiotechnology, Department of Chemistry, Lund University, P.O. Box 124, 221 00, Lund, Sweden.
Javier A Linares-PasténBiotechnology, Department of Chemistry, Lund University, P.O. Box 124, 221 00, Lund, Sweden.
M Alejandra MartinezPlanta Piloto de Procesos Industriales Microbiológicos PROIMI-CONICET, Av. Belgrano Y Pasaje Caseros, T4001 MVB, 4000, San Miguel de Tucumán, Argentina. alejandra.martinez@conicet.gov.ar.ORCID http://orcid.org/0000-0002-9250-3486
Consejo Nacional de Investigaciones Científicas y Técnicas · ARLund University · SENational University of Tucumán · AR

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT-2017-2185Consejo Nacional de Investigaciones Científicas y Técnicas PUE-0012stiftelsen för strategisk forskning IRC15-0068Universidad Nacional de Tucumán VT42-UNT11881
6 · The paper itself

Abstract

The genus Cohnella belongs to a group of Gram-positive endospore-forming bacteria within the Paenibacillaceae family. Although most species were described as xylanolytic bacteria, the literature still lacks some key information regarding their repertoire of xylan-degrading enzymes. The whole genome sequence of an isolated xylan-degrading bacterium Cohnella sp. strain AR92 was found to contain five genes encoding putative endo-1,4-β-xylanases, of which four were cloned, expressed, and characterized to better understand the contribution of the individual endo-xylanases to the overall xylanolytic properties of strain AR92. Three of the enzymes, CoXyn10A, CoXyn10C, and CoXyn11A, were shown to be effective at hydrolyzing xylans-derived from agro-industrial, producing oligosaccharides with substrate conversion values of 32.5%, 24.7%, and 10.6%, respectively, using sugarcane bagasse glucuronoarabinoxylan and of 29.9%, 19.1%, and 8.0%, respectively, using wheat bran-derived arabinoxylan. The main reaction products from GH10 enzymes were xylobiose and xylotriose, whereas CoXyn11A produced mostly xylooligosaccharides (XOS) with 2 to 5 units of xylose, often substituted, resulting in potentially prebiotic arabinoxylooligosaccharides (AXOS). The endo-xylanases assay displayed operational features (temperature optima from 49.9 to 50.4 °C and pH optima from 6.01 to 6.31) fitting simultaneous xylan utilization. Homology modeling confirmed the typical folds of the GH10 and GH11 enzymes, substrate docking studies allowed the prediction of subsites (- 2 to + 1 in GH10 and - 3 to + 1 in GH11) and identification of residues involved in ligand interactions, supporting the experimental data. Overall, the Cohnella sp. AR92 endo-xylanases presented significant potential for enzymatic conversion of agro-industrial by-products into high-value products.Key points• Cohnella sp. AR92 genome encoded five potential endo-xylanases.• Cohnella sp. AR92 enzymes produced xylooligosaccharides from xylan, with high yields.• GH10 enzymes from Cohnella sp. AR92 are responsible for the production of X2 and X3 oligosaccharides.• GH11 from Cohnella sp. AR92 contributes to the overall xylan degradation by producing substituted oligosaccharides.

Indexed as

BacillalesSaccharumEndo-1,4-beta XylanasesHydrolysisOligosaccharidesXylansarabinoxylanEndo-1,4-beta XylanasesOligosaccharidesXylansAgro-industrial by-productsCohnella sp. AR92GH10GH11Molecular dockingXylooligosaccharides

Identifiers

PMID34458936
OpenAlexW3196793328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.